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Ca2+-dependent inactivationDepletion of intracellular Ca2+ stores inmammalian cells results in Ca2+ entry across the plasmamembraneme-
diatedprimarily by Ca2+ release-activatedCa2+ (CRAC) channels. Ca2+ inﬂux through these channels is required
for the maintenance of homeostasis and Ca2+ signaling in most cell types. One of the main features of native
CRAC channels is fast Ca2+-dependent inactivation (FCDI), where Ca2+ entering through the channel binds to
a site near its intracellular mouth and causes a conformational change, closing the channel and limiting further
Ca2+ entry. Early studies suggested that FCDI of CRAC channels was mediated by calmodulin. However, since
the discovery of STIM1 andOrai1 proteins as the basicmolecular components of the CRAC channel, it has become
apparent that FCDI is a more complex phenomenon. Data obtained using heterologous overexpression of STIM1
and Orai1 suggest that, in addition to calmodulin, several cytoplasmic domains of STIM1 andOrai1 and the selec-
tivity ﬁlter within the channel pore are required for FCDI. The stoichiometry of STIM1 binding to Orai1 also has
emerged as an important determinant of FCDI. Consequently, STIM1 protein expression levels have the potential
to be an endogenous regulator of CRAC channel Ca2+ inﬂux. This review discusses the current understanding of
the molecularmechanisms governing the FCDI of CRAC channels, including an evaluation of further experiments
thatmay delineatewhether STIM1 and/or Orai1 protein expression is endogenously regulated tomodulate CRAC
channel function, or may be dysregulated in some pathophysiological states.
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Store-operated Ca2+ channels (SOCs) are a class of plasmamembrane
channels activated upon depletion of intracellular endo/sarcoplasmic
reticulum Ca2+ stores. The most extensively characterised SOC is the
Ca2+ release-activated Ca2+ (CRAC) channel. The importance of CRAC
channels has been demonstrated in many cell types. Physiologically,
CRAC current (ICRAC) is the critical Ca2+ entry mechanism that leads to
activation of T lymphocytes, and genetic loss of function mutations
manifest as severe combined immunodeﬁciency [7,13,43]. Given the
ubiquitous importance of Ca2+ as a signalling molecule, ICRAC has been
identiﬁed as vital in many other processes, including maintenance of
skeletal muscle tone [31,58], ectodermal development [13,31,43], and
tumourigenesis [5,9,67]. Three deﬁning characteristics of native CRAC
channels include: exclusive activation by Ca2+ store depletion, high
selectivity for Ca2+ over monovalent cations, and fast Ca2+-dependent
inactivation (FCDI). FCDI is typically studied in 10mM or higher external
Ca2+ and at hyperpolarised membrane potentials; however, it remains
prominent at physiologically relevant concentrations and membrane
potentials in both overexpressed channels and in native CRAC chan-
nels of Jurkat T cells and RBL-1 cells [8,21,51,52,75]. FCDI may play an
important role in shaping Ca2+ signals and in limiting Ca2+ entry but
due to its complex nature, involving numerous domains and residues
in both STIM1 and Orai1, remains a less well-understood feature of the
CRAC channel. This review discusses the structural elements of STIM1
and Orai1 relevant to FCDI and outlines the current understanding of
the molecular mechanisms underlying Ca2+-dependent gating of the
CRAC channel.
2. Molecular components of CRAC channels
Although CRAC channels were ﬁrst biophysically characterised
twenty years ago [6,17,46,74], investigations into the molecular basis
of CRAC channel activitywere limited until thediscovery of the twopro-
teins that form the functional channel. Stromal Interacting Molecule 1
(STIM1) acts as the endoplasmic/sarcoplasmic reticulum (ER/SR) Ca2+
sensor [26,48], while Orai1 forms the Ca2+ permeable pore on the plas-
ma membrane [34,44,63]. Following depletion of Ca2+ from ER/SR,
STIM1 oligomerises, migrates towards regions of the ER/SR membrane
in direct apposition to the plasma membrane, and interacts with
Orai1. The STIM1/Orai1 complexes form functional CRAC channels
that mediate ICRAC. Ectopic co-expression of STIM1 and Orai1, or its
pore-forming homologues Orai2/3, results in large ICRAC activated byFig. 1. Examples of FCDI and Ca2+-dependent reactivation. Example ICRAC from HEK293 cells w
steps ranging from+62mV to−138mV in 20-mV increments, themost negative step shown i
that whichwould be expectedwhere an excess of STIM1 relative to Orai1 exists. (B) Strongly re
ative to STIM1 exists. The example here shows a longer initial step, demonstrating that the reastore depletion [27,34,53,62]. For a detailed review of the pathway of
CRAC channel activation, see [23].
3. FCDI of CRAC channels
Fast Ca2+-dependent inactivation (FCDI) is a negative feedback
mechanism that was ﬁrst described in voltage-gated Ca2+ channels
[3]. In CRAC channels, FCDI can be observed during whole cell patch
clamp recording by applying voltage steps to negative potentials from
a holding potential of 0 mV after full activation of ICRAC by store deple-
tion [8,18,28,75]. The negative voltage step results in an instant increase
in current through the open CRAC channels, but as Ca2+ passes through
the channel pore, the current inactivates from its peak to a steady state
with a biexponential time course, with time constants of ~10 ms and
100 ms (e.g. Fig. 1A) [8,18,28,75]. The evidence that this type of inacti-
vation gating in the CRAC channel is a Ca2+-dependent process comes
from the extensive testing of the effects of different extracellular and in-
tracellular [Ca2+], and Ca2+ buffers on ICRAC kinetics. FCDI is completely
lost when current is carried by monovalent cations in the absence of
external divalent cations [28,75], while increasing the external Ca2+
concentration results in an accelerated and increased extent of inactiva-
tion [8,75]. Furthermore, the fast Ca2+ buffer 1,2-bis(o-aminophenoxy)
ethane-N,N,N′,N′-tetraacetic acid (BAPTA) in the patch pipette reduces
the extent of inactivation compared to the slower Ca2+ buffer ethylene
glycol tetraacetic acid (EGTA) [8,18,75].
While FCDI has been consistently observed in recordings of endoge-
nous ICRAC, it has been reported to be reduced or absent in over-
expressed STIM1/Orai1 ICRAC [27,50,55,65]. Original investigations
using overexpressed STIM1/Orai1 described ICRAC Ca2+-dependent in-
activation as a complex behavior that included a phase in which current
increased with time [22,27,50]. It was speculated that there may be
three Ca2+-dependent processes occurring: fast and slow exponential
phases of FCDI and a third “reactivation” phase [27]. Several contempo-
rary studies failed to identify a reactivation phase, with FCDI similar or
only slightly weaker than that seen in endogenous ICRAC [55,65].
Two mammalian homologues of Orai1, called Orai2, and Orai3
[7,63], co-expressed with STIM1 are able to reconstitute CRAC-like
currents, albeit with some notable differences in their biophysical
properties [22,27]. The Ca2+-dependent kinetics of Orai2 and Orai3-
mediated currents havebeen reasonably consistent,withOrai2displaying
moderate FCDI and no Ca2+-dependent reactivation [22,27], and Orai3
showing prominent and rapid FCDI and no Ca2+-dependent reactiva-
tion [22,27,50]. To date, the Ca2+ binding site for FCDI and the domainith exogenously expressed STIM1 and Orai1. Traces are recorded in response to the initial
n blue, followed by a second step to−118mV. (A) Strongly inactivating currents, similar to
activating currents, similar to that whichwould be expectedwhere an excess of Orai1 rel-
ctivation fails to approach a steady state even after 600 ms.
Fig. 2. Schematic diagram of Orai1/STIM1 organisation and key domains. Single Orai1 and
STIM1 subunits are labelled, with associated subunits and relevantmembranes unlabelled
and faded for context. Intermolecular interactions are represented by dashed lines. STIM1
is a single transmembrane domain protein located on the endoplasmic reticulum mem-
brane, and during store depletion migrates to regions of the membrane closely apposed
to the plasma membrane. Key domains shown are the Ca2+ binding EF hand domain
pair (green boxes), the SAM domain required for STIM1 oligomerisation (cyan box),
CAD (red box), and CMD (black). Orai1 is located on the plasma membrane with 4 trans-
membrane domains and the N-terminus and C-terminus within in the cytoplasm. Trans-
membrane residues discussed are shown in red. Transmembrane domain 1 lines the
pore, with the selectivity ﬁlter formed by a ring of six E106 residues in the functional
hexameric channel. Key domains marked are CBDOrai1 (cyan), the intracellular
loop (yellow) and the C terminal STIM1 binding region (green). Sequences for highlighted
domains are given with speciﬁc residues discussed in this paper marked in red.
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ﬁed. Some likely candidates are discussed in this review.
4. Channel subunit stoichiometry
The disparity in the kinetics of Ca2+-dependent gating of STIM1/
Orai1-mediated current has led to the suggestion that Orai1 and
STIM1 may form channels with variable stoichiometry. This idea was
supported by experiments in which the expression levels of Orai1 and
STIM1 were varied. Increasing the ratio of STIM1 to Orai1 produced
stronger FCDI (Fig. 1A). In contrast, decreasing the ratio of STIM1 relative
to Orai1 caused a loss of FCDI and introduction of Ca2+-dependent reac-
tivation of ICRAC [51] (Fig. 1B). Associated with the change in the STIM1/
Orai1 ratio were changes in apparent selectivity for Ba2+ and Sr2+ over
Ca2+ and responsiveness to the nonspeciﬁc ICRAC blocker 2-APB [51].
Overexpression of Orai1 without STIM1 overexpression does not
result in any increase in ICRAC and has in some instances been shown
to reduce endogenous ICRAC [34,55,63]. These ﬁndings led to the sugges-
tion that a large excess of Orai1 results in an insufﬁcient pool of STIM1
being able to bind to and activate eachOrai1 channel pore,with the con-
sequence of a reduced whole cell current.
This idea has been supported and extended through the use of ﬂuo-
rescence imaging techniques and concatemers of Orai1 and STIM1 to di-
rectly control or quantify the relative amounts of Orai1 and STIM1
expressed in an individual cell [15,24]. It was initially proposed that
the Orai1 pore functions as a tetramer [20,36,42]. However, recent
data from the crystal structure of the Drosophila melanogaster homo-
logue of Orai suggest that Orai1 forms a hexameric pore [19]. Each
Orai1 subunit can bind two STIM1 subunits as shown by yeast two-
hybrid screens and coimmunoprecipitation experiments where the
activation domain of STIM1 was capable of binding at both C- and
N-termini of Orai1 [41]. The 1 Orai1:2 STIM1 stoichiometry produces
an ICRAC that is maximally activated and shows the greatest degree of
FCDI. In contrast, in the 1 Orai1:1 STIM1 stoichiometry, whole cell cur-
rents are smaller, and Ca2+-dependent reactivation of ICRAC is exhibited
[15,24].
5. Key domains and residues within STIM1
STIM1 was identiﬁed using high throughput RNAi screens in con-
junction with Ca2+ imaging assays to ﬁnd genes that regulate intracel-
lular Ca2+ concentration [26,70]. STIM1 is a ubiquitously expressed
685 amino acid, single transmembrane domain, protein. Cell surface bi-
otinylation shows that as much as 25% of immunoprecipitatable STIM1
is located on the plasma membrane [30]. However, STIM1 required for
CRAC channel activation is located on the endoplasmic reticulummem-
brane [34]. Fig. 2 shows the schematic structure of STIM1, with key do-
mainsmarked. Themature STIM1 protein is cleaved of its N-terminal 22
amino acid signal peptide during translation. The regions required for
Ca2+ sensing and oligomerisation of STIM1 are found within the re-
maining ER/SR luminal N-terminal region (aa. 23–200). This region
contains an ER/SR targeting peptide, a pair of EF-hand domains for ER/
SR luminal Ca2+ sensing, and a sterile α-motif (SAM) domain required
for oligomerisation of STIM1 (Fig. 2) [30,57,64].Within the SAMdomain
are twoN-glycosylation sites thatmodulate the rate of STIM1 transloca-
tion to junctional ER upon store depletion [21].
The cytoplasmic region of STIM1 contains regions critical for interac-
tion with Orai1. The minimum region of STIM1 necessary for CRAC
channel activation is a ~100 amino acid long region known as the
CRAC activation domain (CAD; aa. 342–448) (Fig. 2) [37,41,69]. Ectopic
expression of a construct containing CAD but lacking all other regions of
STIM1 (STIM1-CAD)with any of the Orai proteins is sufﬁcient to cause a
constitutive activation of CRAC current. In contrast, STIM1 constructs
lacking the CAD are unable to activate current following store depletion
[37,41,69]. An interesting property of ICRAC activated by STIM1-CAD is
that it fails to exhibit FCDI [40,69]. The CRAC modulatory domain(CMD; aa. 474–485), C-terminal to CAD, is required for FCDI (Fig. 2)
[4,22,40]. Expression of Orai1 with truncated STIM1 containing CAD
and CMD produces current which retains FCDI. The CMD is rich in neg-
atively charged glutamate and aspartate residues. The role of each of
these negatively charged residues appears to be complex. Alanine
neutralisation of D475/6A and D478/81A in the CMD reduces FCDI,
while E482/3A causes increased and accelerated FCDI [40]. Neutralisation
of six of these residues, including both E482 and E483, completely
abolished FCDI of Orai1 [40].
6. Key domains and residues of Orai1
Orai1 is a 301 amino acid protein that is expressed on the plasma
membrane ofmost cell types. Orai1 is predicted to have four transmem-
brane domains, with N and C termini as well as a single loop within the
cytoplasmic space (Fig. 2).
6.1. N-terminus
The N-terminal residues 74–90 of Orai1 are highly conserved
amongst species and are essential for channel activation; N-terminal
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store depletion [25]. TheN-terminal Calmodulin (CaM) BindingDomain
of Orai1 (CBDOrai1, aa. 68–91) binds CaM in a Ca2+-dependent manner
[40]. Mutations of the CBDOrai1 that prevent CaM binding, e.g. A73E,
W76A, W76E, W76S and Y80E, result in currents with reduced FCDI
and prominent reactivation in response to hyperpolarising steps [40].
In contrast, mutations of the CBDOrai1 that retained CaM binding, Y80A
and Y80S, enhance FCDI [40]. The notion of CaM involvement in
FCDI is consistent with earlier observations that expression of a Ca2+-
insensitive CaM mutant in hepatocytes reduced FCDI of native ICRAC. In
this case, it was hypothesised that the mutant CaM would compete
with wild-type CaM for Ca2+-independent tethering sites on the chan-
nel, exerting a dominant negative effect on FCDI [28]. Consistent with
immunoprecipitation and yeast two-hybrid data [41], the Drosophila
Orai crystal structure reveals that the N-terminus forms a helix that
extends into the cytoplasmic space and is also spatially available to
bind STIM1 [19,49].The N-terminus of Orai1 also contains one
arginine-rich and two proline-rich regions (aa. 1–47), which are either
minimally conserved or completely absent in Orai2 and Orai3. The func-
tion of these regions remains poorly deﬁned. Substitution of the Orai1
N-terminus into Orai3 causes a change in Ca2+-dependent kinetics,
introducing a reactivation phase similar to that of Orai1, but not associ-
atedwith the usual strong inactivation of Orai3.While only a single pro-
line-rich region is required for reactivation of Orai1, all three proline/
arginine-rich regions are required for Orai3 reactivation,making it difﬁ-
cult to deﬁne an essential domain for reactivation and suggesting that
other regions may be involved [11].
6.2. Intracellular loop
The Orai1 intracellular loop between transmembrane domains 2 and
3 is highly conserved betweenOrai1, 2 and 3, and between species, sug-
gesting that it has an important function [10,56]. Consistent with this
notion, co-transfection of STIM1 andOrai1with residues 151–154with-
in the loop mutated to alanine results in an increase in whole cell cur-
rent amplitude in response to store depletion [56]. Associated with
this increase is a complete loss of FCDI. Interestingly, the transfection
of a short peptide derived from the intracellular loopwas able to restore
FCDI, leading the investigators to the suggestion that the intracellular
loop of Orai1 may form the inactivation gate [56]. Similarly, using
chimeric Orai constructs, it has been demonstrated that the intracellular
loop makes a substantial contribution to determining the inactivation
proﬁle of the construct. For example, an Orai1 intracellular loop
substituted into an Orai3 construct displays inactivation similar to
Orai1 [10].
6.3. C terminus
A region of the Orai1 C terminus, identiﬁed as aa. 268–291, contain-
ing a series of charged residues has shown by immunoprecipitation and
yeast two-hybrid assays to interact with STIM1-CAD [39,41]. Deletion of
this region results in a complete loss of ICRAC [25,39,41]. The Drosophila
Orai crystal structure conﬁrmed the availability of this region to bind
STIM1 [19,49].
The C-terminus of Orai1-3 is also likely to regulate FCDI [11,22].
Chimeric Orai constructs where the C-terminus of Orai1, 2 and 3 were
interchanged demonstrated that the characteristic inactivation proper-
ties of the different Orai homologues are inﬂuenced by the C-terminus.
For example, a chimera of Orai1 with an Orai3 intracellular C-terminus
displays robust FCDI similar to wild-type Orai3 [22]. The stronger FCDI
associated with the Orai2 and Orai3 C-termini compared to Orai1 has
led to the hypothesis that a conserved series of three glutamates
found in Orai2 and Orai3, compared to the two present in Orai1, may
be responsible for this phenomenon. Consistent with this, alanine
neutralisation of all three glutamates strongly reduced the extent
of FCDI [22]. In contrast, one report did not ﬁnd any change in theinactivation proﬁle following the swap of only C-termini between
Orai1 and Orai3 but instead suggested that the C-terminus acts in coop-
eration together with the other intracellular domains of Orai3. For ex-
ample, swapping both N- and C-termini had a greater effect than
would be expected from the sum of single N- or C-terminus swaps [11].
6.4. Orai1 pore residues
The transmembrane domain 1 (TM1) of each of the six Orai1 sub-
units that constitute a CRAC channel is understood to line the channel
pore. Mutation analysis has identiﬁed several residues within or near
the TM1 as being important for permeation and therefore likely to be
positioned within the domain's helical structure facing the centre of
the pore [31]. In addition, E190Qmutation in TM3 has also been report-
ed to interfere with permeation [44,62,65]. The transmembrane
residues discussed below have also been reported to modulate Ca2+-
dependent kinetics of ICRAC, suggesting that CRAC channel gating and
permeation may be coupled processes.
Based on the understanding of voltage-gated Ca2+ channels, where
transmembrane glutamates form the selectivity centre [59,66], E106 of
Orai1 in TM1 was identiﬁed as the CRAC channel selectivity centre.
Mutations of E106 of Orai1 to glutamine (E106Q) or alanine (E106A)
have a dominant negative effect, suppressing any WT CRAC current
[12,44,62]. A conservative mutation to aspartate (E106D) [44,62,65],
or of the homologous residue in Drosophila Orai (E180D) [44,68],
produces a channel that retains activation by store depletion when co-
expressed with STIM1 but has altered permeation properties. E106D
Orai1 shifts the reversal potential of STIM1/Orai1-mediated current
towards 0 mV, indicating a loss of selectivity for Ca2+ over monovalent
cations [44,62,68]. These data conclusively demonstrate that E106 of
Orai1 is critical in determining the selectivity of CRAC channels.
In addition to its altered selectivity proﬁle, E106D Orai1 has also
been reported to display altered fast Ca2+-dependent kinetics com-
pared toWT Orai1 [52,65]. Initial investigations of E106D Orai1 showed
that in response to steps to negative membrane potentials, the current
undergoes a very rapid phase of current decay to a steady state in a
bath solution containing 20 mM Ca2+ and 130 mM Na+. This decay
can be ﬁtted with a single exponential with a time constant of approxi-
mately 1.5 ms, which is signiﬁcantly faster than what is normally seen
for FCDI [65]. Since E106D Orai1 is permeable to Na+, and replacement
of all Na+ in the extracellular solution with 110 mM Ca2+ eliminated
this current decay, the investigators reasonably concluded that the ob-
served phenomenon was due to the block of Na+ current by Ca2+
[65]. Consistent with these data, a reduction of extracellular [Ca2+] to
micromolar levels slowed down the kinetics of the block of Na+ current,
while progressive increases of extracellular [Ca2+] accelerated the ki-
netics of the block of Na+ current [65]. The loss of current inactivation
in 110 mM Ca2+ was taken as evidence that the E106D mutant lacks
FCDI and that the mechanism of FCDI may be linked to the selectivity
ﬁlter [65]. Using a different approach, a subsequent study utilised im-
permeable NMDG+ in place of Na+ in the extracellular solution and
found that at lower Ca2+ concentrations, in response to steps to nega-
tive membrane potentials, inactivation of E106D Orai1 current could
be observed and that this inactivation was dependent on extracellular
Ca2+ [52]. The most striking difference between this inactivation and
typical FCDI of WT Orai1 was that it was greatly accelerated and able
to be ﬁtted with a single exponential with a time constant of approxi-
mately 1 ms in 10 mM extracellular Ca2+. The inactivation was found
to be independent of relative STIM1 expression levels and maintained
even if expressed with STIM1-CAD, indicating that the inactivation
was independent of STIM1 [52]. Taken together with data showing
that, unlike FCDI of WT Orai1, the inactivation of the E106D Orai1
could be supported by permeating Sr2+ and that changing the intracel-
lular Ca2+ buffer from EGTA to BAPTA had no effect on the kinetics of
the current, it was concluded that the binding site regulating inactiva-
tion of E106D mutant was different from that of typical FCDI [52]. Two
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teraction between Orai1 and STIM1, or the mechanism of inactivation
within the pore. The clear effects of this mutation strongly suggest
that Ca2+-dependent inactivation is likely to be associated with the
selectivity ﬁlter [52,65].
A V102I mutation of Orai1 was reported to potentiate ICRAC in
response to hyperpolarising steps both in the presence and absence of
Ca2+ [54]. Since this potentiationwas independent from the extracellu-
lar ion composition, it was suggested that this mutation introduces a
slow voltage gate due to interaction of the V102I residue with a gating
charge at the selectivity ﬁlter, presumably at E106 [54]. In contrast,
wild-type STIM1/Orai1 channels have been found to show neither inac-
tivation nor potentiation in the absence of external Ca2+, nomatter how
strong inactivation or potentiation is with external Ca2+ [51,65]. It re-
mains unclear as to whether a purely voltage-dependent gating process
exists for this mutant, or if external Ca2+ is required for potentiation of
ICRAC. A later study found that current mediated by V102I Orai1 is inﬂu-
enced by the relative expression of STIM1/Orai1, and at high STIM1/
Orai1 relative expression displays strong FCDI [52]. The discrepancies
in these ﬁndings relating to the kinetics of V102I Orai1 remain
unresolved.
A second study also suggests that V102I Orai1 is unlikely to be func-
tionally different from WT Orai1; however, other mutations of this
residue suggest that the V102 residue may inﬂuence gating. When mu-
tated from hydrophobic valine to mildly hydrophobic or polar residues,
for example V102C, Orai1 becomes constitutively active, independent of
STIM1 or store depletion, poorly selective for Ca2+ and displays no FCDI
[33]. However, when co-expressed with STIM1, upon store depletion
V102C Orai1 associates with STIM1 and displays high Ca2+ selectivity
and FCDI. These data conﬁrm that interaction with STIM1 changes the
properties of the Orai1 pore and that FCDI is not an intrinsic property
of Orai1 alone [32].
Mutation of E190 in transmembrane domain 3 of Orai1 to aspartate
or alanine has no inﬂuence on Orai1 current. Mutation of the same res-
idue to glutamine (E190Q) has been reported to result in a channel
which is activated by store depletion but displays reduced selectivity
for Ca2+ [44,62,65]. The degree of loss of selectivity associated with
E190Q has been inconsistent between studies [45,62,65] and evidence
that E190C cannot be chemically induced to form disulﬁde bonds, nor
bind permeating Cd2+, implies that E190 is unlikely to line the pore
[33,73]. It has also been suggested that E190Q Orai1 kinetics is
characterised by a Ca2+-dependent reactivation phase [65]. However,
similar to early studies of V102I Orai1 that predated the understanding
of the fundamental importance of the stoichiometry of Orai1/STIM1,
it now seems unlikely that this residue is involved in regulating Ca2+-
dependent kinetics of ICRAC [52].
7. Proposed mechanism for FCDI
The results discussed in this review indicate that FCDI is a complex
process inﬂuenced by 1) the stoichiometry of binding between STIM1
andOrai1, 2) cytoplasmic domains of STIM1 andOrai1, and 3) the selec-
tivity centre within the Orai1 pore. A plausible workingmodel bringing
together many of these concepts to explain the regulation of FCDI of
CRAC channels is similar to that proposed for CaV 1.2, where Ca2+-
dependent CaMbinding to the cytoplasmic site of the channel increases
the afﬁnity of the selectivity ﬁlter for Ca2+, causing Ca2+ to “stick” in the
pore and prevent further ion permeation [1]. Although this exact model
may not necessarily directly apply to FCDI in CRAC channels, it high-
lights the possibility of the interaction between the selectivity centre
in the pore and the CaM binding site in the cytoplasmic domain of the
channel, where Ca2+ binding to one these sites causes a conformational
change at another. Such interaction could explain why E106Dmutation
in the selectivity centre causes very similar changes in ICRAC kinetics [52]
as Y80A (or Y80S) mutation in CBDOrai1[40]. Both mutants, E106D and
Y80A, exhibited greatly accelerated FCDI, compared to WT Orai1,which followed a single exponential time course. It may be that the
E106D mutation allosterically alters the Orai1 CaM binding domain, or
that both the E106D pore mutant and the Y80A/Y80S mutants cause a
similar change in the afﬁnity or efﬁcacy of Ca2+ binding to a site in
the pore, which regulates FCDI.
8. Orai1/STIM1stoichiometry in light of new crystal structure data
The recent discovery of the hexameric crystal structure ofDrosophila
Orai allows the electrophysiological and molecular data regarding
STIM1/Orai1 stoichiometry and FCDI to be analysed in a new light. Inter-
estingly, while the transmembrane region of the channel has a six-fold
symmetry, the cytoplasmic domains adopt two alternating conforma-
tions, conferring a three-fold symmetry where pairs of Orai subunits
have closely interacting C-termini [19]. If a single STIM1 subunit bridges
the N- and C-termini STIM1 binding sites, then this would only allow
three binding sites per channel. STIM1 has been suggested to function
as a dimer [38,69,72]. If this is the case, this would contradict the
model inwhich two STIM1 subunits bind to eachOrai1 subunit formax-
imal ICRAC activation [49]. However, the level of oligomerisation of
STIM1 subunits remains undeﬁned, and it has also been suggested
that STIM1may function as a tetramer, given that STIM1-CAD forms tet-
ramers in solution [41].
The conformation of the Orai1 C-termini in activated Orai1-STIM1
complexes remains unknown. It has been speculated that perhaps in
the activated state, the initial STIM1 interaction may disrupt the Orai
pairing, and instead the C-termini extend directly down into the cyto-
plasm to reveal six binding sites [19]. While these models can possibly
explain how STIM1 can bind Orai1 in a 2:1 ratio, they do not explicitly
account for how other possible stoichiometries may activate the chan-
nel and display weaker FCDI or reactivation.
One possibility is that in a hypothetical extended conformation,
there exists enough space for an STIM1 subunit each to bind to both
the N- and C-termini, giving twelve binding sites. As demonstrated by
Park et al. (2009), STIM1-CAD binds to both the C-terminus and N-
terminus of Orai1, with a higher afﬁnity for the C-terminus [41]. It
would therefore be reasonable to suggest that when the ER/SR is nearly
full and STIM1 concentration at the junctional ER is low, available Ca2+
binding sites associated with STIM1-CAD would only be present at the
C-terminus which would favour Ca2+-dependent reactivation. In con-
trast, when ER/SR Ca2+ is fully depleted and the amounts of STIM1
are saturating, STIM1-CAD occupies both N- and C-terminal binding
sites onOrai1,whichmay create a completely different set of Ca2+ bind-
ing sites, and/or different type of conformational changes in response to
Ca2+ binding, favouring FCDI.
In a model where a single STIM1 subunit within a dimer bridges the
N- and C-termini Orai1 binding sites, this gives six STIM1 binding sites.
In this case, when two or fewer sites are occupied, the channel is closed,
as at least one STIM1 subunit per Orai subunit is required for channel
activation [15]. Once three sites are occupied, the channel opens, and
with each subsequent STIM1 dimer binding, the open probability or sin-
gle channel conductance increases, resulting in increased whole cell
ICRAC. In a CRAC channel where only a minimum required number, for
a functional channel, of STIM1 binding sites on Orai1 are occupied,
Ca2+ entering through the pore promotes reactivation, whereas in a
channel with all or almost all STIM1 binding sites occupied, entering
Ca2+ causes FCDI.
9. Future perspectives
There are currently no physiological examples of ICRAC displaying
FCDI associated with low STIM1 expression relative to Orai1, such as
Ca2+-dependent reactivation. One possible example in an experimental
setting is thedistinct ICRAC Ba2+ conductances ofmast cells, RBL and Jurkat
cells [16]. We have previously found that differences in STIM1:Orai1 ex-
pression were also associated with differences in Ba2+ conductance [51].
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quent variable ICRAC properties may have functional signiﬁcance. The
activation of store-operated channels is graded depending on the level
of intracellular store depletion [2,14,29], presumably by recruitment of
additional activated STIM1 as stores are progressively depleted. There-
fore, FCDI would be graded in a similar manner to ICRAC amplitude,
where during partial depletion with a relatively small amount of acti-
vated STIM1, small currents with little or no FCDI would be likely and
during full depletion large currentswith strong FCDIwould be expected.
The kinetics of ICRAC activated in response to partial store depletion has
not been thoroughly investigated, though one study did not report any
changes in kinetics under these conditions [29]. In addition, little is
known about the physiological regulation of Orai1 and STIM1 expres-
sion in many cell types, or if expression changes during development,
or during stressful or pathophysiological conditions. There is some
evidence that thesemaybe the case, for example in the dynamic expres-
sion patterns of STIM1 throughout muscle development [58], oncogene
or tumour suppressor-dependent expression of STIM1 in a model can-
cer cell line [47], and altered expression of STIM1 and Orai1 during T
cell activation [60], or following vascular injury [71]. Future work is
likely to focus on endogenous regulation mechanisms of STIM and
Orai protein expression, given that these data have provided the frame-
work to link in vivo examples of altered relative STIM1/Orai1 expression
with the functional consequences of altered Ca2+ signaling. In addition,
the formation of heteromeric STIM1/Orai channels is an intriguing con-
cept that remains largely unexplored. There is conclusive evidence that
heteromeric Orai channels are able to be formed [27,35,50,62] and,
given the functional differences between Orai subunits, may be able to
display a wide range of characteristics and be tuned for speciﬁc roles
in certain tissues or under certain conditions.
10. Conclusions
The discovery of STIM1 and Orai1 has underpinned rapid advance-
ments in the understanding of CRAC channel function over the past
eight years. In that time, the pathway from store depletion to channel
activation has been well deﬁned, and the functional signiﬁcance of
many individual domains of Orai1 and STIM1 has been described, if
not yet synthesised into a “whole channel” model. The recent publica-
tion of crystal structure data for Drosophila Orai offers a new set of chal-
lenges and opportunities. The ﬁnding of a hexameric pore may force a
reevaluation ofmany results that presumed a tetrameric pore. However,
recent electrophysiological data obtained using Orai1 concatamers sug-
gest that classical ICRAC ismediated by Orai1 tetramer, not hexamer [61].
Given the importance of the stoichiometry of STIM1:Orai1 binding and
the functional signiﬁcance of the cytoplasmic domains of both STIM1
and Orai1 on ICRAC properties as discussed in this review, a full under-
standing of CRAC channel Ca2+-dependent gatingwill require the addi-
tional knowledge of how Orai1 and STIM1 subunits are organised in the
functional channel.
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